Coherus BioSciences, Inc.

Historical 13F Holders

Symbol
CHRS
CUSIP
19249H103
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 19249H103 since 12/18/2024, largest first.

Filer % of Class Filed
Timothy G. Youngquist 2020 Irrevocable Trust 13G/A 8.3% 5/15/2026
Event 3/31/2026
Bering Partners II, L.P. 13G
6.5% 11/4/2025
Event 9/5/2025
BlackRock, Inc. 13G 5.8% 7/27/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Thomas A. Satterfield, Jr. 13G/A 4.6% 4/29/2026
Event 3/31/2026
Rubric Capital Management LP 13G/A
4.6% 2/13/2025
Event 12/31/2024
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 46 19.6 M $23.7M
2026 Q2 147 70.4 M $100M
2026 Q1 159 71.6 M $121M
2025 Q4 130 57.3 M $81.4M
2025 Q3 115 51.7 M $84.8M
2025 Q2 114 55.7 M $40.7M
2025 Q1 120 62.0 M $50.0M
2024 Q4 128 65.7 M $90.6M
2024 Q3 130 77.4 M $126M
2024 Q2 138 84.5 M $146M
2024 Q1 138 88.4 M $212M
2023 Q4 160 85.6 M $283M
2023 Q3 170 94.1 M $349M
2023 Q2 163 86.8 M $371M
2023 Q1 167 78.7 M $538M
2022 Q4 165 85.5 M $677M
2022 Q3 175 77.7 M $746M
2022 Q2 177 78.9 M $572M
2022 Q1 185 76.1 M $981M
2021 Q4 203 82.4 M $1.32B
2021 Q3 189 76.1 M $1.22B
2021 Q2 192 82.6 M $1.14B
2021 Q1 209 85.0 M $1.24B
2020 Q4 197 86.9 M $1.51B
2020 Q3 204 88.2 M $1.62B
2020 Q2 192 86.8 M $1.55B
2020 Q1 189 74.7 M $1.21B
2019 Q4 190 73.7 M $1.33B
2019 Q3 169 69.4 M $1.41B
2019 Q2 147 67.8 M $1.50B
2019 Q1 119 68.8 M $938M
2018 Q4 114 66.3 M $600M
2018 Q3 112 67.6 M $1.12B
2018 Q2 118 66.1 M $926M
2018 Q1 105 56.0 M $619M
2017 Q4 97 49.5 M $436M
2017 Q3 95 47.0 M $628M
2017 Q2 108 40.1 M $576M
2017 Q1 114 37.6 M $795M
2016 Q4 125 30.1 M $848M
2016 Q3 118 28.1 M $754M
2016 Q2 87 25.4 M $429M
2016 Q1 76 18.2 M $387M
2015 Q4 79 16.7 M $384M
2015 Q3 79 16.2 M $334M
2015 Q2 75 15.1 M $434M
2015 Q1 52 7.27 M $222M
2014 Q4 38 9.87 M $158M